Microbiotica (private company)
See something wrong or missing? Let us know
Offices:Cambridge
Industry:BiotechHealth servicesManufacturing
Business model:B2B
Microbiotica is a developer of human microbiome therapeutics from the UK via a platform which uses the body’s trillions of resident bacteria known as the microbiome, to discover and develop therapeutic medicines and biomarkers for a range of disorders. Its current areas of focus are cancer immunotherapy and inflammatory bowel disease.
Investors:
we tracked 6 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 66.55M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Microbiotica
Name | Criteria | |
---|---|---|
![]() |
CatalYm
70%
|
|
![]() |
Salvia BioElectronics
70%
|
|
![]() |
Synendos Therapeutics
70%
|
|
![]() |
Cytoki Pharma
70%
|
|
![]() |
Eyevensys
70%
|
|
![]() |
Mestag Therapeutics
70%
|
|
![]() |
Emergence Therapeutics
70%
|
|
![]() |
PDC*line pharma
70%
|
|
![]() |
Atlantic Therapeutics
70%
|
|
![]() |
Sixfold Bioscience
70%
|
|